Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? - Wikidata - wikimedia - TriplyDB

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

http://www.wikidata.org/entity/Q42134434

about

The functional anatomy of impulse control disorders Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology Amphetamine sensitization alters reward processing in the human striatum and amygdala.The risky business of dopamine agonists in Parkinson disease and impulse control disorders.Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans Targeting impulsivity in Parkinson's disease using atomoxetine Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders.An Integrative Perspective on the Role of Dopamine in Schizophrenia Decision-making and trait impulsivity in bipolar disorder are associated with reduced prefrontal regulation of striatal reward valuation.Sensitivity and bias in decision-making under risk: evaluating the perception of reward, its probability and value Deep brain stimulation of nucleus accumbens region in alcoholism affects reward processing Examining dorsal striatum in cognitive effort using Parkinson's disease and fMRI.Impulsive and compulsive behaviors in Parkinson's disease Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors Serotonin and dopamine play complementary roles in gambling to recover losses.Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.Differential effects of Parkinson's disease and dopamine replacement on memory encoding and retrieval Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity.Impulse control disorders in Parkinson's disease: clinical characteristics and implications.Imaging insights into basal ganglia function, Parkinson's disease, and dystonia Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.Amping up effort: effects of d-amphetamine on human effort-based decision-making.The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease.Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains Parkinson's disease and healthy aging: independent and interacting effects on action selection.Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling.Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson's Disease.Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease Impulse control disorders in Parkinson's disease: background and update on prevention and management.Impulsivity and apathy in Parkinson's disease.Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.Dopaminergic influences on emotional decision making in euthymic bipolar patients Pathological gambling in Parkinson's disease: what are the risk factors and what is the role of impulsivity?Imaging cognitive and behavioral symptoms in Parkinson's disease.Pathological gambling in Parkinson's disease: disease related or drug related?

P2860

Q22252597-2017FEB5-BB74-4090-9F95-32CE3640F6AB Q24616099-976BCD42-D71C-4812-B739-BEE6D7C9F7C8 Q26738349-AB4F05A4-A16F-4B9A-9866-56F5B0E5135D Q28537648-90C4D8C6-A314-4E50-8BAA-074273479C1F Q30425695-0C970A47-0681-40E7-9C4E-AC318C524FAF Q30498096-A9D380DA-C938-4FA3-908C-700F090A9BC4 Q33593384-1917E858-C27E-453B-844B-8B68BC528D3C Q33657211-26810F2C-6BFB-4C1D-8D42-C43E8C169AE2 Q33687660-962E86C5-03DE-45D4-BE78-EBB154EF350D Q33706269-83E0E80B-9303-4B3C-97A1-0101539A7241 Q33784038-3ED01E4C-8ECD-4D50-A1B9-03371906A497 Q33800742-F9A1C9BA-1EF7-4D82-94C2-FB91A8786DAC Q33839379-D7C9DE5B-8ED2-4734-8FD0-DBD867D462A3 Q33937513-7D88AE6B-A7BB-4695-911A-5F87C31C880E Q34228264-EF6DB2AF-B151-43FD-AC66-24AFF5DD5080 Q34281618-728AD6C5-46F9-475C-9437-81AC5FE58FDA Q34286740-5A276DD8-D2CE-4BD1-A0DC-B2D187B9F610 Q34342432-0BC275E9-5844-4A3B-B730-CAD6AFBF5C79 Q34660481-1F93052D-990B-4503-99D1-25803B814B07 Q34661794-1B4E84F3-94E5-4AE8-94C3-5F492352277D Q34711985-9E3D35D2-9D0C-4E55-BDA6-3CA408F04931 Q35004866-7C89227B-1000-46EE-ACAC-3093FBAC0877 Q35007644-41FB5497-109A-49F4-A85D-C31A9EC17E0F Q35059774-863E88DC-473F-439E-A6E5-CFFB5D34FAED Q35193033-C3BDF82A-F2A3-46FD-92D7-FCDB84C7436B Q35402798-D046426A-FA4C-4ED3-9621-FBA54E3DF242 Q35605151-D67470BF-BA8A-4408-85F2-F06A6C3A3CE0 Q35760266-B436ECC7-D3AC-4742-9E1C-2FF77D4442B6 Q35870180-E1652187-E66B-45B9-AE3E-8C69127DE188 Q35963542-604119E8-1D1D-4E94-8C94-A6A8F6B5BD2C Q36286365-5737B94D-34CF-49AF-B5E5-029E410D4DF0 Q36332819-61BD0123-FA2A-4C40-8434-79A9A7C9525E Q36568655-B58E3896-AED8-484E-9DCB-AD9F922EFE1F Q36768304-7FCDE8C7-D6BC-4492-9A4B-6BB83982028A Q37331607-FB9B186F-5DB0-4FA8-B85C-45546D4F849F Q37364568-0DB69A1A-EDD6-4EC7-B419-BC6F59889AEC Q37409558-9E0F1B28-B977-4910-B434-92C3E6465D8E Q37561079-286F246C-FE33-4989-B64A-50120F2EE4D7 Q37810993-979198F8-9DF5-4371-9015-C4B837D5EBEB Q37886145-562FD280-AA3A-4138-BE30-0CE5E81E7390

P2860

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

http://www.wikidata.org/entity/Q42134434

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@en

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@nl

type

label

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@en

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@nl

prefLabel

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@en

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@nl

P1433

Q42134434-293EC5E3-BA77-4D0F-908A-0B2343AE4CEA

P1476

Q42134434-5E3BAC83-CE5D-43BE-AB6B-32E1D1E32EA8

P2093

Q42134434-0D7F3E9E-016B-4353-A768-8D4B67745DC5

Q42134434-192C77CF-C86D-4EE0-8B9A-BAE2BA2827E2

Q42134434-7BD8DAEE-EE93-4F98-8D72-DF3184ED1727

P2860

Q42134434-05710044-4BF4-4C38-A00A-0FF62D9672AB

Q42134434-09848512-BDFC-4B50-98F8-D3F53952AF18

Q42134434-0E01BB6B-3FDA-4A7D-89C0-A5945DCEAA03

Q42134434-10A20BF3-CAFF-499A-A2B4-89C670F82BE0

Q42134434-12A00DEE-6837-44A4-BEF4-D9E7E3704D1C

Q42134434-134935EB-CA69-4869-9D6A-55C405B8BA41

Q42134434-218F2465-8543-4F5F-9299-9BAA45263712

Q42134434-2808D5A8-1617-49FA-A36B-13F25382CFAA

Q42134434-2ECFCADA-BA08-45AA-97A6-C3CF05829CEE

Q42134434-304EE769-F6DD-4FF3-B5E9-3243B66174A7

P2888

Q42134434-685781FD-2551-41A7-99C5-B6E8CD61A4D1

P304

Q42134434-D4573E35-6633-45E3-870F-D7D9E5D7D9B2

P31

Q42134434-453977F0-231A-4442-AFCE-9BDFA58D7824

P356

Q42134434-D29DACC1-2DE1-40C0-BF32-78F0A497E1F3

P407

Q42134434-985539EA-A690-4463-9EDD-4E6C6196729A

P433

Q42134434-2323AF88-7C6C-4A95-9522-E14F610EED36

P478

Q42134434-C0D01B90-80DD-4FA6-85BD-C49E49F0868D

P50

Q42134434-03754230-20FF-4E69-93ED-C6946325125C

Q42134434-A23E6392-A567-4DE9-B44B-C39CE6F52312

Q42134434-C87ABB77-ABC1-44A6-AFCF-D8D301D8D73E

P577

Q42134434-C1FCD484-82AB-4CD9-86C5-80C5D2EA1D43

P6179

Q42134434-882D5454-A95E-44CD-8B08-C4C15BD337E6

P698

Q42134434-D4173266-F539-49FA-BDA6-C8B6B8C193CB

P921

Q42134434-52f18a7f-474c-4e00-b58c-54ffad019425

Q42134434-D784F8EC-5727-4097-BB9C-B6C9629168D0

Q42134434-F86B37D0-AFF8-48BB-B1C7-C52A9375694D

P932

Q42134434-33D29BF8-0B27-4959-AE07-8483A6D919B6

P356

P1433

Neuropsychopharmacology

P1476

Dopamine agonists diminish val ...... mbling in Parkinson's disease?

@en

P2093

Bénédicte Ballanger

http://www.w3.org/2001/XMLSchema#string

Giovanna Pellecchia

http://www.w3.org/2001/XMLSchema#string

Thilo van Eimeren

http://www.w3.org/2001/XMLSchema#string

P2860

Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Circular analysis in systems neuroscience: the dangers of double dipping

Getting formal with dopamine and reward

Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers.

The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies.

Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology.

Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents.

Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli.

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.

P2888

P304

2758-2766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2009.124

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Janis M. Miyasaki

Antonio P Strafella

P577

2009-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021166490

http://www.w3.org/2001/XMLSchema#string

P698

19741594

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

orbitofrontal cortex

P932

2972251

http://www.w3.org/2001/XMLSchema#string